Cormedix Inc (CRMD)

R&D Expense Growth

-7.32%

Quarterly · Period ending:

CRMD logo

CRMD R&D Expense Growth

Latest reported-7.32%
CRMD Quarterly R&D Growth (QoQ) (0.00% → -7.32%)
High-resolution chart · PNG

CRMD r&d expense growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Cormedix Inc R&D Expense Growth — Quarterly
Period endingR&D Expense Growth
-7.3211%
-16.1416%
68.7094%
108.6881%
-23.4846%
84.8847%
137.4741%
11.6947%
-22.265%
-63.4126%
-14.08%
-44.4398%
40.7118%
19.8465%
21.5432%
-27.1136%
40.2994%
-29.2911%
-31.7641%
88.1288%
-4.4049%
14.9014%
-21.5675%
-48.5452%
129.9767%
-7.6537%
6.1886%
-15.4003%
3.6491%
166.1335%
-152.4456%
25.5882%
-20.2915%
-2.099%
40.6319%
18.1671%
3.358%
22.1195%
-41.0513%
146.6828%
32.7034%
40.6894%
-15.8244%
-1.8425%
45.6109%
146.3615%
71.2059%
70.2377%
-51.2974%
286.6744%
-124.8574%
94.9833%
47.216%
-14.1854%
20.7666%
3.0412%
-33.7904%
197.5012%
-122.2903%
9.0024%
34.6058%
9.2092%
41.534%
35.6423%
-81.8937%
-20.4831%
728.2981%
61.4628%
25.0575%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.